
Legal5 Jul 2026, 02:30 pm
Medplus Subsidiary's Drug License Suspended for 5 Days in Maharashtra
AI Summary
Medplus Health Services Ltd announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License for a store located in Nashik, Maharashtra. The suspension is for a period of five days, effective from July 4, 2026. This action is based on alleged violations of Rule 65 of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945. The company estimates a potential revenue loss of ₹0.75 lacs due to this suspension. The details of the order will be available on the company's website and stock exchange websites.
Key Highlights
- Subsidiary's drug license suspended for five days in Maharashtra.
- Action taken by Food & Drug Administration, Nashik.
- Potential revenue loss estimated at ₹0.75 lacs.
- Violation cited under Drugs and Cosmetics Act, 1940.
Price Impact
More from MEDPLUS